Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US7608616 | GALT PHARMS | Methods for reducing the risk of an adverse drug interaction in a patient suffering from insomnia |
Jun, 2028
(4 years from now) |
Market Authorisation Date: 26 February, 1987
Treatment: Method for treating insomnia while reducing the risk of an adverse drug interaction
Dosage: TABLET;ORAL